Highly variable antigenic site located at the apex of GII.4 norovirus capsid protein induces cross-reactive blocking antibodies in a variant-specific manner., PMID:40444947
Manipulation of immunodominant variable epitopes of norovirus capsid protein elicited cross-blocking antibodies to different GII.4 variants despite the low potency of the polyclonal sera., PMID:40444946
A broadly protective human antibody for GI genogroup noroviruses., PMID:40211068
An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial., PMID:40043138
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus., PMID:40043137
Vaccinia Virus Vector Bivalent Norovirus Vaccine., PMID:40006992
Effect of trypsin digestion on the integrity and antigenic epitopes of GII.6 norovirus virus-like particles., PMID:39762616
H and B Blood Antigens Are Essential for In Vitro Replication of GII.2 Human Norovirus., PMID:39758750
Preliminary establishment and evaluation of a rapid detection method for GII human norovirus based on time-resolved fluorescence chromatography., PMID:39744883
The use of human intestinal enteroid cell cultures for detection of multiple gastroenteric viruses., PMID:39724953
Two Monoclonal Antibodies Targeting Distinct Subdomains of Human Norovirus P Protein., PMID:39463379
Patterns of the within-host evolution of human norovirus in immunocompromised individuals and implications for treatment., PMID:39396425
Development of genogroup-specific ELISAs based on the VP1 protein to detect antibodies to GIV and GVI feline norovirus., PMID:39292300
Replication-deficient Sendai virus expressing human norovirus capsid protein elicits robust NoV-specific antibody and T-cell responses in mice., PMID:39236991
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge., PMID:39203972
A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice., PMID:38997087
Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses., PMID:38953655
Identification of a norovirus GII-specific antigenic epitope., PMID:38819530
Structural analyses of the GI.4 norovirus by cryo-electron microscopy and X-ray crystallography revealing binding sites for human monoclonal antibodies., PMID:38593321
The reversible activation of norovirus by metal ions., PMID:38236007
SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion., PMID:37424789
Identification of a GII.6 norovirus blockade antibody epitope., PMID:37392840
Linear epitopes on the capsid protein of norovirus commonly elicit high antibody response among past-infected individuals., PMID:37280660
Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response., PMID:37280322
Direct Blockade of the Norovirus Histo-Blood Group Antigen Binding Pocket by Nanobodies., PMID:36971561
Minimal Antigenic Evolution after a Decade of Norovirus GII.4 Sydney_2012 Circulation in Humans., PMID:36688654
High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity., PMID:36528444
Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein., PMID:36389818
Generation of Recombinant Rotaviruses Expressing Human Norovirus Capsid Proteins., PMID:36314817
Profiling of humoral immune responses to norovirus in children across Europe., PMID:35995986
Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study., PMID:35953727
Distinct dissociation rates of murine and human norovirus P-domain dimers suggest a role of dimer stability in virus-host interactions., PMID:35680964
Dynamic immunodominance hierarchy of neutralizing antibody responses to evolving GII.4 noroviruses., PMID:35417705
Recombinant norovirus capsid protein VP1 (GII.4) expressed in H5 insect cells exhibits post-translational modifications with potential impact on lectin activity and vaccine design., PMID:35312780
Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity., PMID:35106126
Assignment of Ala, Ile, LeuproS, Met, and ValproS methyl groups of the protruding domain of murine norovirus capsid protein VP1 using methyl-methyl NOEs, site directed mutagenesis, and pseudocontact shifts., PMID:35050443
Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology., PMID:34894525
Structural Studies on the Shapeshifting Murine Norovirus., PMID:34834968
Identification of Human Norovirus GII.3 Blockade Antibody Epitopes., PMID:34696487
Receptor profile and immunogenicity of the non-epidemic norovirus GII.8 variant., PMID:34662679
Multiple Signals in the Gut Contract the Mouse Norovirus Capsid To Block Antibody Binding While Enhancing Receptor Affinity., PMID:34468172
Prolonged norovirus infections correlate to quasispecies evolution resulting in structural changes of surface-exposed epitopes., PMID:34355146
Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses., PMID:34262046
Identification of a blockade epitope of human norovirus GII.17., PMID:33929932
Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses., PMID:33836574
A Norovirus Uses Bile Salts To Escape Antibody Recognition While Enhancing Receptor Binding., PMID:33827952
Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade Antibodies., PMID:33466932
RNA-assisted self-assembly of monomeric antigens into virus-like particles as a recombinant vaccine platform., PMID:33465537
Broad-range and effective detection of human noroviruses by colloidal gold immunochromatographic assay based on the shell domain of the major capsid protein., PMID:33430771
Structural heterogeneity of a human norovirus vaccine candidate., PMID:33202318
For research use only. Not for human or drug use.
